- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Canbridge Pharmaceuticals Inc (1228)
"Canbridge Pharmaceuticals Inc stock price live, this page displays HK 1228 stock exchange data. View the 1228 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Canbridge Pharmaceuticals Inc real time stock price chart below.
What Is the Canbridge Pharmaceuticals Inc Stock Price Today?
The Canbridge Pharmaceuticals Inc stock price today is 0.14.
What Is the Stock Symbol for Canbridge Pharmaceuticals Inc?
The stock symbol for Canbridge Pharmaceuticals Inc is ""1228.""
What Stock Exchange Does Canbridge Pharmaceuticals Inc Trade On?
Canbridge Pharmaceuticals Inc is listed and trades on the Hong Kong stock exchange.
Is Canbridge Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Canbridge Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1228 quote. (ISIN: KYG1821D1097)"
What Is the Canbridge Pharmaceuticals Inc Stock Price Today?
The Canbridge Pharmaceuticals Inc stock price today is 0.14.
What Is the Stock Symbol for Canbridge Pharmaceuticals Inc?
The stock symbol for Canbridge Pharmaceuticals Inc is ""1228.""
What Stock Exchange Does Canbridge Pharmaceuticals Inc Trade On?
Canbridge Pharmaceuticals Inc is listed and trades on the Hong Kong stock exchange.
Is Canbridge Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Canbridge Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1228 quote. (ISIN: KYG1821D1097)"
Hong Kong
Currency in HKD
0.14
+0.01(+7.81%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.13
0.14
52 wk Range
0.10
0.50
1228 Scorecard
Full Analysis
Operates with a significant debt burden
Unusual trading volume
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.130.14
52 wk Range
0.100.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1228 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
May have trouble making interest payments on debt
Canbridge Pharmaceuticals Inc Company Profile
CANbridge Pharmaceuticals Inc., a biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare diseases and oncology indications worldwide. The company offers Hunterase, an enzyme replacement therapy for the treatment of Hunter syndrome; NERLYNX (Neratinlib), a potent irreversible tyrosine kinase inhibitor for HER2-positive breast cancer; and Livmarli, an oral, minimally-absorbed, reversible IBAT inhibitor for the treatment of alagille syndrome and progressive familial intrahepatic cholestasis. It also engages in the development of CAN008, a CD95-Fc fusion protein that is in Phase 2/3 clinical trial for the treatment of glioblastoma multiforme; CAN106, an anti-C5 mAb that has completed Phase I clinical trial for paroxysmal nocturnal hemoglobinuria; and CAN103, a recombinant human enzyme replacement therapy (ERT) that is in Phase 2/3 clinical trials for gaucher disease. In addition, the company develops CAN107, a fibroblast growth factor 23 (FGF23) blocking antibody for X-linked hypophosphatemia; CAN104, a recombinant human ERT GLA for fabry disease; CAN105, a bispecific antibody for the treatment of hemophilia A; CAN201, a gene therapy program that utilizes adeno-associated virus (AAV) sL65 capsid; CAN202, a gene therapy program utilizing AAV sL65 capsid for pompe disease; and CAN 203, a gene therapy program that utilizes AAV SMN1 for the treatment of spinal muscular atrophy. It has a license agreement with Mirum for the development, commercialization, and manufacturing, under certain conditions, of Livmarli. CANbridge Pharmaceuticals Inc. was founded in 2012 and is headquartered in Suzhou, China.
Compare 1228 to Peers and Sector
Metrics to compare | 1228 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1228PeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.1x | −13.1x | −0.5x | |
PEG Ratio | 0.01 | 0.37 | 0.00 | |
Price/Book | −0.1x | 4.2x | 2.6x | |
Price / LTM Sales | 0.6x | 8.3x | 2.9x | |
Upside (Analyst Target) | - | 20.7% | 53.0% | |
Fair Value Upside | Unlock | 1.9% | 8.9% | Unlock |
Earnings
Latest Release
Mar 31, 2025
EPS / Forecast
-0.46 / --
Revenue / Forecast
40.31M / --
FAQ
What Is the Canbridge Pharmaceuticals (1228) Stock Price Today?
The Canbridge Pharmaceuticals stock price today is 0.14
What Stock Exchange Does Canbridge Pharmaceuticals Trade On?
Canbridge Pharmaceuticals is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for Canbridge Pharmaceuticals?
The stock symbol for Canbridge Pharmaceuticals is "1228."
What Is the Canbridge Pharmaceuticals Market Cap?
As of today, Canbridge Pharmaceuticals market cap is 54.34M.
What Is Canbridge Pharmaceuticals's Earnings Per Share (TTM)?
The Canbridge Pharmaceuticals EPS (TTM) is -1.04.
From a Technical Analysis Perspective, Is 1228 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.